BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Provided By PR Newswire
Last update: Nov 14, 2024
Conference call planned for later in Q4 2024 to provide updates on NurOwn® program
NEW YORK, Nov. 14, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the third quarter ended September 30, 2024 and provided a corporate update.
Read more at prnewswire.comNASDAQ:BCLI (2/21/2025, 8:02:56 PM)
1.73
-0.07 (-3.89%)
Find more stocks in the Stock Screener
